نتایج جستجو برای: pulmonary arterial hypertension pah

تعداد نتایج: 446651  

2014
Raya Saba James Davis Arvind Balavenkataraman Aibek E. Mirrakhimov Aram Barbaryan Shyam Chalise Nkemakolam Iroegbu

Pulmonary arterial hypertension (PAH) has been reported as a major complication to consider and promptly manage in the use of ethanol sclerotherapy. Most of the available data on the development of PAH is derived from the use of ethanol for embolization of arteriovenous malformation, but it has been rarely reported in its other fields of application. We describe a case of outpatient renal arter...

Journal: :Rheumatology 2004
D Mukerjee D St George C Knight J Davar A U Wells R M Du Bois C M Black J G Coghlan

OBJECTIVE A prospective study to evaluate echocardiography and gas transfer (DLCO) by comparison with cardiac catheterization in discriminating between patients with and without systemic sclerosis-associated pulmonary arterial hypertension (SScPAH). METHOD A total of 137 (52 with and 85 without pulmonary fibrosis) had echocardiography and lung function tests within 3 months of their definitiv...

2017
Kazufumi Nakamura Hiromi Matsubara Satoshi Akagi Toshihiro Sarashina Kentaro Ejiri Norifumi Kawakita Masashi Yoshida Toru Miyoshi Atsuyuki Watanabe Nobuhiro Nishii Hiroshi Ito

Nanoparticles have been used as a novel drug delivery system. Drug-incorporated nanoparticles for local delivery might optimize the efficacy and minimize the side effects of drugs. The efficacy and safety of intratracheal administration of prostacyclin analog (beraprost) -incorporated nanoparticles and imatinib (a PDGF-receptor tyrosine kinase inhibitor) -incorporated nanoparticles in Sugen-hyp...

Journal: :Circulation 2011
Jay L Zweier M A Hassan Talukder

Pulmonary arterial hypertension (PAH) is a devastating and life-threatening clinical syndrome characterized by elevated pulmonary artery pressures leading to progressive symptoms, including shortness of breath, fatigue, and a decline in functional ability. The hemodynamic definition of PAH is a mean pulmonary artery pressure of 25 mm Hg at rest or 30 mm Hg during exercise, with a normal pulmona...

2017
Janani Baskaran Kimara S. March Thenappan Thenappan

Late-onset pulmonary arterial hypertension (PAH) is a rare but fatal complication in patients with childhood surgical repair of dextro-transposition of great arteries (D-TGA), especially with the Mustard and Senning procedures. The pathogenic mechanisms of PAH in patients with repaired D-TGA are not well understood and treatment is not standardized. In this manuscript, we present a case of late...

2012
Rajendrakumar Patel Wilbert S. Aronow Laxeshkumar Patel Kaushang Gandhi Harit Desai Dhiraj Kaul Sumir P. Sahgal

Pulmonary arterial hypertension (PAH) is a chronic progressive disease of the pulmonary vasculature characterized by elevated pulmonary arterial pressure and secondary right ventricular failure. PAH is considered a life-threatening condition unless treated. This article provides a comprehensive review of controlled and uncontrolled trials to define the risk-benefit for different therapeutic opt...

Journal: :The Journal of clinical investigation 2015
Ankang Lu Caojian Zuo Yuhu He Guilin Chen Lingjuan Piao Jian Zhang Bing Xiao Yujun Shen Juan Tang Deping Kong Sara Alberti Di Chen Shenkai Zuo Qianqian Zhang Shuai Yan Xiaochun Fei Fei Yuan Bin Zhou Shengzhong Duan Yu Yu Michael Lazarus Yunchao Su Richard M Breyer Colin D Funk Ying Yu

Pulmonary arterial hypertension (PAH) is commonly associated with chronic hypoxemia in disorders such as chronic obstructive pulmonary disease (COPD). Prostacyclin analogs are widely used in the management of PAH patients; however, clinical efficacy and long-term tolerability of some prostacyclin analogs may be compromised by concomitant activation of the E-prostanoid 3 (EP3) receptor. Here, we...

2012
Alejandro Roldán-Alzate Oliver Wieben Alex Frydrychowicz Naomi C Chesler Christopher Francois

Background The pulmonary circulation is a highly compliant system that generates little resistance to blood flow. However, in the presence of pulmonary arterial hypertension (PAH), blood pressure and vascular resistance in the pulmonary circulation are elevated. This leads to distension and stiffening of the main pulmonary artery (MPA) and vessel wall remodeling, which in itself may influence s...

2016
Süreyya Yilmaz Yasar Yildirim Mahsuk Taylan Melike Demir Zülfükar Yilmaz Ali Veysel Kara Fatma Aydin Hadice Selimoglu Sen Aziz Karabulut Fusun Topcu

BACKGROUND Pulmonary arterial hypertension (PAH) is common disease among hemodialysis (HD) patients and is associated with increased morbidity and mortality. However, its pathogenesis has not been completely elucidated. We aimed to evaluate the frequency of PAH in HD patients, as well as the relationship between fluid status and PAH. MATERIAL AND METHODS We enrolled 77 HD patients in this study...

2013
Onno A. Spruijt Harm-Jan Bogaard Anton Vonk-Noordegraaf

A congenital extrahepatic portosystemic venous shunt (CEPVS), also known as an Abernethy malformation, is a rare cause of pulmonary arterial hypertension (PAH). In this case series, we describe three male patients of 30, 23, and 27 years of age with PAH due to a CEPVS. In all three patients, a right heart catheterization revealed a high cardiac output. The aim of this case series is to make pul...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید